FIELD: medicine.
SUBSTANCE: invention refers to medicine associated with surgical management of malignant tumours. Disclosed is a pharmaceutical composition for intraoperative imaging of lymph nodes by indirect colour lymphography, containing as a lymphotropic dye a mixture of blue triphenylmethane dye - disodium salt of 4-{[(4-diethylamino)phenyl][4-(diethylimino)-cyclohexa-2,5-diene-1-ylidene]-methyl}benzo-1,3-disulphonate, sodium dihydrophosphate and potassium dihydrophosphate, with the following ratio of components in mg per 1 ml: 5.0–20.0:6.6:2.7.
EFFECT: invention provides enlarging the range of diagnostic agents for indirect colour lymphography and lymphotropic properties.
8 cl, 4 dwg, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EXTRACTING LYMPHOTROPIN FROM INDUSTRIAL DYE "DISULPHINE BLUE" | 2021 |
|
RU2782930C2 |
| METHOD OF PRODUCING DYE ISOSULFAN BLUE (4-{[4-DIETHYLAMINO)PHENYL](2,5-DISULFOPHENYL)METHYLIDENE}-N,N-DIETHYLCYCLOHEXA-2,5-DIENE-1-IMINIUM) | 2023 |
|
RU2821634C1 |
| METHOD FOR CLEARING DISULFO DERIVATIVE DIAMINO TRIPHENYLMETHANE DYE | 2017 |
|
RU2654862C1 |
| METHOD FOR PRODUCING PURIFIED ACID BRIGHT BLUE DYE | 2022 |
|
RU2787434C1 |
| METHOD OF FLUORESCENT DETERMINATION OF SPEED OF LYMPH FLOW FROM BREAST TO REGIONAL LYMPHOCOLLECTORS | 2023 |
|
RU2805793C2 |
| COMBINATION OF MUSCARINE RECEPTOR ANTAGONIST AND BETA-2-ADRENORECEPTOR AGONIST | 2008 |
|
RU2460527C2 |
| METHOD OF SPECTRAL SENSITIZING OF SILVER-HALIDE EMULSIONS TO 500-790- NM SPECTRUM ZONE | 1996 |
|
RU2100834C1 |
| AMINOPYRIMIDINE KINASE INHIBITORS | 2012 |
|
RU2674017C2 |
| COMPOSITE FOR KERATIN FIBER STAINING AND METHOD OF STAINING USING THIS COMPOSITE | 1998 |
|
RU2193391C2 |
| PHOTOGRAPHIC HALOGEN-SILVER SUBSTANCE | 1997 |
|
RU2125735C1 |
